Skip to content
City AM
Main navigation
Download free app
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Insurance
      • Square Mile and me
      • Tech
      • Legal
      • Banking
      • Property
      • Retail
      • Crypto
      • Transport
    • From our partners
      • AON
      • Tottenham Hotspur Stadium
      • Eastern City BID
      • London Stansted Airport
      • YourCause from Blackbaud
      • Inside Saudi
      • Central London Alliance CIC
    • Featured

      Three Iranian men charged with spying offences under National Security Act

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
      • The Punter
    • From our partners
      • The Morning Briefing: SBS x City AM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Danny Care: Harlequins No9 a brilliant player

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      Italy, Call Me By Your Name style: staying at Luca Guadagnino’s hotel

      Submit a story

      Tell us your story.

      Submit
  • Personal Finance
  • CityAM Awards
  • Newsletters
  • Latest Paper
  • Sign In
  • Sign Out
  • My Account

Wegovy

  • Is your business about to feel the Ozempic squeeze? 

    Opinion

    Reshaping stomachs with weightloss drugs like Ozempic likely means reshaping some markets (and probably your strategy), says Paul Armstrong Ozempic, Wegovy, and Mounjaro are driving a subtle but undeniable shift in obesity rates across the U.S, showing a 2 per cent drop so far. While it’s too soon to crown these drugs the cure-all, their [...]

  • Digital health firm explores London listing amid surge in demand for weight-loss jabs

    Healthcare

    Digital health business Reset Health is mulling a potential listing on London's stock market as it looks to pounce on the boom in demand for weight-loss jabs.

  • Ozempic and Wegovy: What happens when a drug goes viral?

    Wegovy

    Novo Nordisk's Wegovy and Ozempic have been heralded as the solution to the world's growing obesity problems. But when celebrities and influencers misuse them and start documenting their weight loss journeys online, should we take stock?

Trending Articles

  • M&S to make £100m cyber claim from Allianz and Beazley

  • Exclusive: JP Morgan's City of London office vandalised

  • Salford Red Devils hit with winding-up by tax authorities

  • How Steven Bartlett's first Dragons' Den investment collapsed

Subscribe

Subscribe to the City AM newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • About us
  • Careers
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Opinion
  • Life&Style
  • Personal Finance
  • Got a story?
  • The Punter
  • City AM Curated
  • Wine
  • Casino

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
  • Newsletters
  • Advertising
  • About
  • Tickets
Copyright 2025 City AM Limited